Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Nicole E. Scangarella-Oman, MS
Scientific Director
GlaxoSmithKline plc.
Poster(s):
(2159) Analysis of Resistance to Oral Standard-of-Care Antibiotics for Urinary Tract Infections Caused By
Escherichia coli
and
Staphylococcus saprophyticus
Collected in the United States in 2022
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2832) Gepotidacin Efficacy in
E. coli
Drug-Resistant Phenotypes: A Pooled Analysis of the EAGLE-2 and EAGLE-3 Randomized Controlled Trials in Uncomplicated Urinary Tract Infection
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2837) Impact of Regulatory Guidelines on Therapeutic, Clinical, and Microbiological Success Rates in Uncomplicated Urinary Tract Infection: Results from a Two Phase 3 Randomized Controlled Trials of Oral Gepotidacin (EAGLE-2 and EAGLE-3)
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
